article thumbnail

Ethical Considerations in Medical Sales: Maintaining Integrity in a Competitive Industry

Rep-Lite

While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction. Let’s explore!

Ethics 52
article thumbnail

Generative AI: Revolutionizing Pharmaceutical Industry and Driving Precision Medicine With Innovation, Equity and Ethics

MedCity News

Generative AI plays a pivotal role by analyzing genetic, physiological, and clinical data to tailor treatments to individual patients. This not only enhances treatment efficacy but also minimizes adverse effects, improving patient outcomes and quality of life. Photo: metamorworks, Getty Images

Ethics 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Ethics 105
article thumbnail

The Pillars of Trust: Regulatory Compliance in Patient Engagement

PM360

This is especially relevant in biopharmaceutical patient engagement, where regulatory infractions can have existential consequences. In this context, we shouldn’t just think of the Sacklers and Shkrelis and Holmeses of the world, who coupled regulatory noncompliance with lamentable ethical failures.

article thumbnail

Framework to enable re-use of patient clinical data

European Pharmaceutical Review

FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice.

article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

Any modification in the manufacturing process could drastically impact the structure or the effectiveness of the product for patients, inciting a major public health threat. Novavax is particularly sensitive to this matter and is looking for alternatives that will not only benefit the patients but align with a more ethical solution.

Ethics 83
article thumbnail

ViiV, Roche and Pfizer top in ESG, according to patients

European Pharmaceutical Review

According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.